RADIOPHARM THERANOSTICS LIMITED (RAD)

---

AI Coverage Rating: High

ASX AI Signals has generated 9 signals for RAD during the last 90 days, indicating strong trading activity and ongoing AI monitoring

Latest RAD Signals
03/07/2026	BUY
25/06/2026	SELL
18/05/2026	BUY
RAD Share Price
Current Price	$0.020
52 Week High	$0.037
52 Week Low:	$0.018
Trading at (% of 52 Week High)	54.05%

Business Overview

Radiopharm Theranostics Limited (ASX: RAD) is an Australian company that develops and commercializes diagnostic and therapeutic products for cancer treatment using radiopharmaceuticals. The company focuses on advancing precision medicine through targeted imaging and therapy solutions.

ASX Sector Overview

Sector:   Pharmaceuticals, Biotechnology & Life Sciences

The Pharmaceuticals, Biotechnology & Life Sciences sector on the ASX includes companies involved in the development, production, and commercialization of drugs, medical devices, and biotechnology products. This sector covers activities such as research and development of new medicines, genetic testing, and innovative healthcare technologies. Companies often work on treatments for diseases, including cancer, infectious diseases, and chronic conditions. The sector plays a crucial role in advancing medical science and improving patient care through innovation.

Latest AI Recommendation

The BUY signal for RADIOPHARM THERANOSTICS LIMITED (RAD) at a very low price point suggests speculative potential but is accompanied by significant risks including liquidity and volatility concerns. The confidence level remains low due to limited market capitalization and potential operational uncertainties.

Latest  RADIOPHARM THERANOSTICS LIMITED(RAD)   News

03 Nov 2025, 08:06 PM

RADX: Program and Financial Updates

By John Vandermosten, CFA NASDAQ:RADX READ THE FULL RADX RESEARCH REPORT On October 28th, Radiopharm Theranostics Limited (NASDAQ:RADX) announced its first quarter cash flows in its Activities and Cash Flow Report, disclosing a cash balance of A$19.0 million as of September 30th, 2025. During the

21 Jun 2022, 10:43 PM

UPDATE -- Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on June 23, 2022

Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional Investors NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will h

27 Apr 2022, 11:00 PM

Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV

LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at Bally's Hotel & Casino in Las Vegas, NV. Event website: www.PlanetMicroCapShowcase.com The Planet Mi

16 Feb 2022, 01:00 AM

Diamond Equity Research to Host Emerging Growth Invitational Virtual Investor Conference on February 24, 2022

Presenting Companies to Host 25 Minute Presentations Followed by Question-and-Answer Session; Conference Open to all Retail and Institutional Investors NEW YORK, Feb. 15, 2022 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading small-capitalization equity research and conference provider, will h